Breaking News

Quintiles Partners with Russian Investment Firm

Will expand clinical development in Russia

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles and Russian Venture Company Biofund, a Russian-based investment firm, have entered an agreement to support expansion of clinical development services in Russia. The two companies will work to address Russia’s healthcare initiatives in accordance with its Healthcare 2020 Development Program. This will include implementing best practices to support medical science and the development of healthcare in line with international standards. “With a population of almost 140 million, Russia is...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters